• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ID2通过在一个多效增强子处拮抗E蛋白来确保cDC1的分化。

ID2 secures cDC1 specification by antagonizing E proteins at a pleiotropic enhancer.

作者信息

Ou Feiya, Liu Tian-Tian, Du Siling, Chen Jing, Koch Alyssa R, Kraft Magdalena, Murphy Theresa L, Murphy Kenneth M

机构信息

Department of Pathology and Immunology, Washington University in St. Louis School of Medicine, St. Louis, MO, USA.

Present address: Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.

出版信息

Res Sq. 2025 Sep 4:rs.3.rs-7455813. doi: 10.21203/rs.3.rs-7455813/v1.

DOI:10.21203/rs.3.rs-7455813/v1
PMID:40951272
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12425045/
Abstract

The transcriptional regulator ID2 is required for type 1 classical dendritic cell (cDC1) specification, yet the mechanism has remained obscure. We previously identified the -165-kb enhancer as key to normal hematopoiesis, controlled by competing CEBP and NFIL3 inputs during myeloid dendritic cell divergence. Here, we uncover an unprecedented role for E proteins in myelopoiesis and demonstrate that ID2 promotes cDC1 development by antagonizing E protein activity at E-boxes within the enhancer. Deleting these E-boxes abolishes lymphoid B cell and plasmacytoid dendritic cell (pDC) development while skewing myelopoiesis toward cDC1s. Remarkably, E-box deletion rescues cDC1 development in -deficient mice. These findings support a two-step model in which NFIL3 transiently represses , followed by ID2-mediated inhibition of E proteins to stabilize cDC1 fate specification. Further, this work defines a paradigm of "site-specific pleiotropy," wherein distinct transcription factor motifs-E-boxes and CEBP sites-within a single enhancer direct diverse cell fates.

摘要

转录调节因子ID2是1型经典树突状细胞(cDC1)分化所必需的,但具体机制仍不清楚。我们之前鉴定出-165-kb增强子是正常造血的关键,在髓样树突状细胞分化过程中受竞争性的CEBP和NFIL3输入控制。在此,我们揭示了E蛋白在髓系造血中的前所未有的作用,并证明ID2通过拮抗增强子内E-boxes处的E蛋白活性促进cDC1的发育。删除这些E-boxes会消除淋巴B细胞和浆细胞样树突状细胞(pDC)的发育,同时使髓系造血偏向cDC1。值得注意的是,E-box缺失挽救了ID2缺陷小鼠中cDC1的发育。这些发现支持了一个两步模型,其中NFIL3短暂抑制增强子,随后ID2介导对E蛋白的抑制以稳定cDC1命运分化。此外,这项工作定义了一种“位点特异性多效性”模式,其中单个增强子内不同的转录因子基序——E-boxes和CEBP位点——指导不同的细胞命运。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7d2/12425045/0b491591b6b3/nihpp-rs7455813v1-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7d2/12425045/0c7043a187d0/nihpp-rs7455813v1-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7d2/12425045/fa563b75c2d4/nihpp-rs7455813v1-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7d2/12425045/fe760407d5cc/nihpp-rs7455813v1-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7d2/12425045/7694c9f0423d/nihpp-rs7455813v1-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7d2/12425045/6e16521f7a24/nihpp-rs7455813v1-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7d2/12425045/fe3e0cadf316/nihpp-rs7455813v1-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7d2/12425045/0b491591b6b3/nihpp-rs7455813v1-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7d2/12425045/0c7043a187d0/nihpp-rs7455813v1-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7d2/12425045/fa563b75c2d4/nihpp-rs7455813v1-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7d2/12425045/fe760407d5cc/nihpp-rs7455813v1-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7d2/12425045/7694c9f0423d/nihpp-rs7455813v1-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7d2/12425045/6e16521f7a24/nihpp-rs7455813v1-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7d2/12425045/fe3e0cadf316/nihpp-rs7455813v1-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7d2/12425045/0b491591b6b3/nihpp-rs7455813v1-f0007.jpg

相似文献

1
ID2 secures cDC1 specification by antagonizing E proteins at a pleiotropic enhancer.ID2通过在一个多效增强子处拮抗E蛋白来确保cDC1的分化。
Res Sq. 2025 Sep 4:rs.3.rs-7455813. doi: 10.21203/rs.3.rs-7455813/v1.
2
Ablation of cDC2 development by triple mutations within the Zeb2 enhancer.通过 Zeb2 增强子内的三重突变消融 cDC2 的发育。
Nature. 2022 Jul;607(7917):142-148. doi: 10.1038/s41586-022-04866-z. Epub 2022 Jun 22.
3
An Nfil3-Zeb2-Id2 pathway imposes Irf8 enhancer switching during cDC1 development.Nfil3-Zeb2-Id2 通路在 cDC1 发育过程中诱导 Irf8 增强子切换。
Nat Immunol. 2019 Sep;20(9):1174-1185. doi: 10.1038/s41590-019-0449-3. Epub 2019 Aug 12.
4
Type 1 conventional dendritic cells regulate innate immunity during fungal pneumonia.1型传统树突状细胞在真菌性肺炎期间调节固有免疫。
mBio. 2025 Sep 22:e0256425. doi: 10.1128/mbio.02564-25.
5
T-bet expressing Tr1 cells driven by dietary signals dominate the small intestinal immune landscape.由饮食信号驱动的表达T-bet的Tr1细胞主导小肠免疫格局。
bioRxiv. 2025 Jul 4:2025.06.30.662190. doi: 10.1101/2025.06.30.662190.
6
Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells.肿瘤细胞向1型常规树突状细胞样细胞的可诱导体内重编程
J Vis Exp. 2025 Aug 1(222). doi: 10.3791/68739.
7
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
8
Aspects of Genetic Diversity, Host Specificity and Public Health Significance of Single-Celled Intestinal Parasites Commonly Observed in Humans and Mostly Referred to as 'Non-Pathogenic'.人类常见且大多被称为“非致病性”的单细胞肠道寄生虫的遗传多样性、宿主特异性及公共卫生意义
APMIS. 2025 Sep;133(9):e70036. doi: 10.1111/apm.70036.
9
cDC1s Promote Atherosclerosis via Local Immunity and Are Targetable for Therapy.浆细胞样树突状细胞1通过局部免疫促进动脉粥样硬化,且是可靶向治疗的。
Circ Res. 2025 Jul 18;137(3):400-416. doi: 10.1161/CIRCRESAHA.124.325792. Epub 2025 May 30.
10
C/EBPα activates expression in myeloid progenitors at the +56-kb enhancer to initiate cDC1 development.C/EBPα 在 +56-kb 增强子处激活髓系祖细胞中的表达,以启动 cDC1 发育。
Sci Immunol. 2025 May 16;10(107):eadt5899. doi: 10.1126/sciimmunol.adt5899.

本文引用的文献

1
C/EBPα activates expression in myeloid progenitors at the +56-kb enhancer to initiate cDC1 development.C/EBPα 在 +56-kb 增强子处激活髓系祖细胞中的表达,以启动 cDC1 发育。
Sci Immunol. 2025 May 16;10(107):eadt5899. doi: 10.1126/sciimmunol.adt5899.
2
Transcriptional function of E2A, Ebf1, Pax5, Ikaros and Aiolos analyzed by in vivo acute protein degradation in early B cell development.通过体内急性蛋白降解分析早期 B 细胞发育过程中 E2A、Ebf1、Pax5、Ikaros 和 Aiolos 的转录功能。
Nat Immunol. 2024 Sep;25(9):1663-1677. doi: 10.1038/s41590-024-01933-7. Epub 2024 Aug 23.
3
Cell-type-directed design of synthetic enhancers.
合成增强子的细胞类型定向设计。
Nature. 2024 Feb;626(7997):212-220. doi: 10.1038/s41586-023-06936-2. Epub 2023 Dec 12.
4
Enhanced in vitro type 1 conventional dendritic cell generation via the recruitment of hematopoietic stem cells and early progenitors by Kit ligand.Kit 配体通过募集造血干细胞和早期祖细胞增强体外 1 型传统树突状细胞的生成。
Eur J Immunol. 2023 Sep;53(9):e2250201. doi: 10.1002/eji.202250201. Epub 2023 Jul 9.
5
pDC-like cells are pre-DC2 and require KLF4 to control homeostatic CD4 T cells.pDC 样细胞是前 DC2 细胞,需要 KLF4 来控制稳态 CD4 T 细胞。
Sci Immunol. 2023 Feb 24;8(80):eadd4132. doi: 10.1126/sciimmunol.add4132.
6
Site pleiotropy of a stickleback Bmp6 enhancer.棘鱼 Bmp6 增强子的位点多效性。
Dev Biol. 2022 Dec;492:111-118. doi: 10.1016/j.ydbio.2022.09.012. Epub 2022 Oct 2.
7
Dntt expression reveals developmental hierarchy and lineage specification of hematopoietic progenitors.Dntt 表达揭示了造血祖细胞的发育层次结构和谱系特化。
Nat Immunol. 2022 Apr;23(4):505-517. doi: 10.1038/s41590-022-01167-5. Epub 2022 Mar 30.
8
Differential usage of transcriptional repressor Zeb2 enhancers distinguishes adult and embryonic hematopoiesis.转录抑制因子 Zeb2 增强子的差异使用区分了成人和胚胎造血。
Immunity. 2021 Jul 13;54(7):1417-1432.e7. doi: 10.1016/j.immuni.2021.04.015. Epub 2021 May 17.
9
A RUNX-CBFβ-driven enhancer directs the Irf8 dose-dependent lineage choice between DCs and monocytes.RUNX-CBFβ 驱动的增强子指导 DC 和单核细胞之间 Irf8 剂量依赖性谱系选择。
Nat Immunol. 2021 Mar;22(3):301-311. doi: 10.1038/s41590-021-00871-y. Epub 2021 Feb 18.
10
A Shared Regulatory Element Controls the Initiation of Expression During Early T Cell and Innate Lymphoid Cell Developments.一个共享的调控元件控制着早期 T 细胞和先天淋巴细胞发育过程中表达的起始。
Front Immunol. 2020 Mar 20;11:470. doi: 10.3389/fimmu.2020.00470. eCollection 2020.